Patents by Inventor Magdalena Usategui Gomez

Magdalena Usategui Gomez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4112064
    Abstract: Angiotensin I and iodinated angiotensin I solutions are stabilized against enzymatic degradation by the addition of phenylmethylsulfonyl fluoride (PMSK). Such solutions are used as standards and reagents in immunoassay kits for determinatin of plasma renin levels. Stabilized solutions prepared in accordance with this disclosure can be shipped at ambient temperature which represents a substantial advantage in convenience over previously available solutions of angiotensin I and radioiodinated angiotensin I.
    Type: Grant
    Filed: February 22, 1977
    Date of Patent: September 5, 1978
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Bruce Charles Farrenkopf, Magdalena Usategui Gomez
  • Patent number: 4104367
    Abstract: An improved immunoassay for methadone is disclosed. The subject radioimmunoassay utilizes a novel antigen, antibody and novel labelled methadone derivatives.
    Type: Grant
    Filed: October 13, 1976
    Date of Patent: August 1, 1978
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Magdalena Usategui Gomez, Harvey Gurien, John Edward Heveran, Manfred Weigele
  • Patent number: 3952091
    Abstract: Compositions useful for conducting a plurality of different radioimmuno-assays simultaneously and methods for preparing same. The compositions radioimmunoassaya a plurality of labeled antigens and their respective antibodies present in selected concentrations so that the response curves observed for each antigen are essentially superimposable on the response curve of all other antigens present in the composition. Particularly preferred compositions include a mixture of radiolabeled morphine, a radiolabeled 5- or 5,5-substituted barbituric acid, i.e., secobarbital and their respective antibodies useful for performing a bivalent radioimmunoassay and a mixture of radiolabeled morphine, radiolabeled amphetamine, a radiolabeled 5- or 5,5-substituted barbituric acid and their respective antibodies useful for performing a trivalent radioimmunoassay.
    Type: Grant
    Filed: October 23, 1974
    Date of Patent: April 20, 1976
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Emanuel Grunberg, Magdalena Usategui Gomez